Prasugrel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3366 publications

Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI.

Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI.

Journal: The New England journal of medicine

Published: August 31, 2026

Prasugrel versus Ticagrelor in Acute Coronary Syndromes.

Prasugrel versus Ticagrelor in Acute Coronary Syndromes.

Journal: The New England journal of medicine

Published: August 31, 2026

Rare delayed thromboembolic complication 18 days after Woven EndoBridge implantation: A case report.

Rare delayed thromboembolic complication 18 days after Woven EndoBridge implantation: A case report.

Journal: Surgical neurology international

Published: July 21, 2026

Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.

Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.

Journal: Cureus

Published: July 16, 2026

Antithrombotic Drug Eruptions in Dermatology Practice: Selection Bias, Clinical Phenotypes, and Diagnostic Approaches.

Antithrombotic Drug Eruptions in Dermatology Practice: Selection Bias, Clinical Phenotypes, and Diagnostic Approaches.

Journal: Cureus

Published: July 15, 2026

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Journal: Nature medicine

Published: July 02, 2026

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Journal: Thrombosis and haemostasis

Published: June 24, 2026

Comparative Efficacy and Safety of Ticagrelor and Prasugrel in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

Comparative Efficacy and Safety of Ticagrelor and Prasugrel in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

Journal: Cardiology in review

Published: June 23, 2026

Cyclodextrin nanosponges enhance the oral pharmacokinetics and antiplatelet efficacy of prasugrel hydrochloride in Wistar rats.

Cyclodextrin nanosponges enhance the oral pharmacokinetics and antiplatelet efficacy of prasugrel hydrochloride in Wistar rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 13, 2026

Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes.

Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes.

Journal: Thrombosis and haemostasis

Published: June 05, 2026

ABCD-GENE Score and Bleeding in Post-PCI Patients: Implications for Guided De-Escalation of Antiplatelet Therapy.

ABCD-GENE Score and Bleeding in Post-PCI Patients: Implications for Guided De-Escalation of Antiplatelet Therapy.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: June 02, 2026

"Ticagrelor or Prasugrel, Doctor?": A Yet Unresolved Conundrum Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.

"Ticagrelor or Prasugrel, Doctor?": A Yet Unresolved Conundrum Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Journal: The Canadian journal of cardiology

Published: May 29, 2026

Showing 1-12 of 3,366

Last Updated: 09/26/2026